Abstract

Preparation and Characterization of Chitosan Nanoparticles "Alternatively, Carrying Potential" for Cellular and Humoral Immune Responses

Highlights

  • Chitosan is a natural biodegradable polysaccharide, co– polymer of N–acetyl–d–glucosamine and d–glucosamine (Onishi and Machida, 1999) obtained by the alkaline deacetylation of chitin, which is a polysaccharide found in the exoskeleton of crustaceans of marine arthropods and insects (Romoren et al, 2002)

  • Chitosan is available in a broad range of molecular weights and its properties can be modified by changing the degree of deacetylation and the environment of the formulation (Davis and Illum, 2003)

  • Diluted colloidal dispersions of nanoparticles in pure distilled water were used for size and zeta potential measurement as per the standard procedure followed at National Institute of Immunology (NII), New Delhi

Read more

Summary

INTRODUCTION

Chitosan is a natural biodegradable polysaccharide, co– polymer of N–acetyl–d–glucosamine and d–glucosamine (Onishi and Machida, 1999) obtained by the alkaline deacetylation of chitin, which is a polysaccharide found in the exoskeleton of crustaceans of marine arthropods and insects (Romoren et al, 2002). Numerous studies in mice and human (Davis and Illum, 2003; Moschos et al, 2004) have demonstrated that chitosan and their soluble derivatives are effective and safe adsorption enhancers to improve nasal and peroral delivery of hydrophilic antigens such as peptide and protein drugs and heparins In these models, the absorption enhancing effect is caused by the opening of the intercellular tight junctions, thereby favouring the paracellular transport of macromolecular drugs, and by slowing down mucociliary clearance, maintaining the contact of antigen with the mucosa for a longer period of time, thereby facilitating higher drug and carrier bioavailability. We prepared chitosan nanoparticles and characterized their encapsulation efficiency, size and charges which are important factors determining the uptake of antigen by APC and development of immune responses for sustained vaccine effects

MATERIALS AND METHODS
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.